Viking Therapeutics
VKTX
VKTX
386 hedge funds and large institutions have $4.26B invested in Viking Therapeutics in 2024 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 164 increasing their positions, 102 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.29% less ownership
Funds ownership: 73.22% → 72.93% (-0.29%)
35% less capital invested
Capital invested by funds: $6.56B → $4.26B (-$2.3B)
54% less funds holding in top 10
Funds holding in top 10: 13 → 6 (-7)
Holders
386
Holding in Top 10
6
Calls
$421M
Puts
$185M
Top Buyers
| 1 | +$123M | |
| 2 | +$95.2M | |
| 3 | +$64.2M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$59.3M |
| 5 |
D.E. Shaw & Co
New York
|
+$23.8M |
Top Sellers
| 1 | -$294M | |
| 2 | -$119M | |
| 3 | -$38M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$29.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$28.6M |